Interview to Forbes: SARS-CoV-2 Prion-Like Domains in Spike Proteins Enable Higher Affinity to ACE2

Interview to Forbes : SARS-CoV-2 Prion-Like Domains in Spike Proteins Enable Higher Affinity to ACE2

In the interview to Forbes Dr. George Tetz highlights possible major scientific breakthroughs based on his article “SARS-CoV-2 Prion-Like Domains in Spike Proteins Enable Higher Affinity to ACE2

The full text is available at: https://www.forbes.com/sites/jvchamary/2020/04/17/prion-like-coronavirus/#6ea4b8df4680